Willatts S - Search Results

1

Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis.

Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL; EASy-Study Group. Reinhart K, et al. Among authors: willatts s. Crit Care Med. 2004 Aug;32(8):1662-8. doi: 10.1097/01.ccm.0000132902.54925.b5. Crit Care Med. 2004. PMID: 15286541 Clinical Trial.

2

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

Reinhart K, Wiegand-Löhnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J. Reinhart K, et al. Among authors: willatts s. Crit Care Med. 1996 May;24(5):733-42. doi: 10.1097/00003246-199605000-00003. Crit Care Med. 1996. PMID: 8706447 Clinical Trial.

3

Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.

Willatts SM, Radford S, Leitermann M. Willatts SM, et al. Crit Care Med. 1995 Jun;23(6):1033-9. doi: 10.1097/00003246-199506000-00007. Crit Care Med. 1995. PMID: 7774213 Clinical Trial.

4

Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.

Willatts SM, Speller DC, Winter RJ. Willatts SM, et al. Anaesthesia. 1994 Sep;49(9):751-4. doi: 10.1111/j.1365-2044.1994.tb04443.x. Anaesthesia. 1994. PMID: 7978126 Free article. Clinical Trial.

5

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R. López A, et al. Among authors: willatts s. Crit Care Med. 2004 Jan;32(1):21-30. doi: 10.1097/01.CCM.0000105581.01815.C6. Crit Care Med. 2004. PMID: 14707556 Clinical Trial.

6

Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety.

Spencer EM, Willatts SM. Spencer EM, et al. Among authors: willatts sm. Intensive Care Med. 1992;18(7):415-21. doi: 10.1007/BF01694344. Intensive Care Med. 1992. PMID: 1469180 Clinical Trial.

7

Sweet's syndrome associated with systemic inflammatory response syndrome.

Matthews PC, Willatts SM. Matthews PC, et al. Among authors: willatts sm. Intensive Care Med. 1998 Oct;24(10):1106-9. doi: 10.1007/s001340050724. Intensive Care Med. 1998. PMID: 9840248

8

Isoflurane sedation in pediatric intensive care.

Kong KL, Willatts SM. Kong KL, et al. Among authors: willatts sm. Crit Care Med. 1995 Jul;23(7):1308-9. doi: 10.1097/00003246-199507000-00027. Crit Care Med. 1995. PMID: 7600844 No abstract available.

9

A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection.

Winter R, Humphreys H, Pick A, MacGowan AP, Willatts SM, Speller DC. Winter R, et al. Among authors: willatts sm. J Antimicrob Chemother. 1992 Jul;30(1):73-87. doi: 10.1093/jac/30.1.73. J Antimicrob Chemother. 1992. PMID: 1429339 Clinical Trial.

10

An outbreak of aspergillosis in a general ITU.

Humphreys H, Johnson EM, Warnock DW, Willatts SM, Winter RJ, Speller DC. Humphreys H, et al. Among authors: willatts sm. J Hosp Infect. 1991 Jul;18(3):167-77. doi: 10.1016/0195-6701(91)90141-t. J Hosp Infect. 1991. PMID: 1680899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters